Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q3FY25 of ₹1,146.00 Crores up from ₹1,105.00 Crore year on year, a rise of 3.71%.
Total Expenses for Q3FY25 of ₹869.00 Crores up from ₹827.00 Crores year on year, a rise of 5.08%.
Consolidated Net Profit of ₹233.00 Crores up 10.95% from ₹210.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹18.64, up 13.73% from ₹16.39 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
